Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Biosimilars: opinion of an expert panel in the Middle East.
Bohlega S, Al-Shammri S, Al Sharoqi I, Dahdaleh M, Gebeily S, Inshasi J, Khalifa A, Pakdaman H, Szólics M, Yamout B. Bohlega S, et al. Among authors: szolics m. Curr Med Res Opin. 2008 Oct;24(10):2897-903. doi: 10.1185/03007990802381554. Epub 2008 Sep 2. Curr Med Res Opin. 2008. PMID: 18768104 Review.
Characteristics of multiple sclerosis in the Middle East with special reference to the applicability of international guidelines to the region.
Al Tahan AM, Alsharoqi I, Bohlega SA, Dahdaleh M, Daif A, Deleu D, Esmat K, Giampaolo D, Freedman MS, Gwilt M, Hosny H, Inshasi JS, Aljumah M, Khalifa A, Pakdaman H, Szólics M, Yamout BI, Sahraian MA, Zakaria MF. Al Tahan AM, et al. Among authors: szolics m. Int J Neurosci. 2014 Sep;124(9):635-41. doi: 10.3109/00207454.2013.865620. Epub 2013 Dec 18. Int J Neurosci. 2014. PMID: 24228830 Review.
The use of alemtuzumab in patients with relapsing-remitting multiple sclerosis: the Gulf perspective.
Alroughani R, Van Wijmeersch B, Al Khaboori J, Alsharoqi IA, Ahmed SF, Hassan A, Inshasi J, Krieger DW, Shakra M, Shatila AO, Szolics M, Khallaf M, Ezzat A. Alroughani R, et al. Among authors: szolics m. Ther Adv Neurol Disord. 2020 Sep 16;13:1756286420954119. doi: 10.1177/1756286420954119. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32973927 Free PMC article. Review.
Position of Cladribine Tablets in the Management of Relapsing-Remitting Multiple Sclerosis: An Expert Narrative Review From the United Arab Emirates.
Inshasi JS, Alfahad S, Alsaadi T, Hassan A, Zein T, Mifsud VA, Nouri SI, Shakra M, Shatila AO, Szolics M, Thakre M, Kumar A, Boshra A. Inshasi JS, et al. Among authors: szolics m. Neurol Ther. 2021 Dec;10(2):435-454. doi: 10.1007/s40120-021-00243-6. Epub 2021 Apr 23. Neurol Ther. 2021. PMID: 33891277 Free PMC article. Review.
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study.
Inshasi J, Farouk S, Shatila A, Hassan A, Szolics M, Thakre M, Kayed D, Krieger D, Almadani A, Alsaadi T, Benedetti B, Mifsud V, Jacob A, Sayegh S, Boshra A, Alroughani R. Inshasi J, et al. Among authors: szolics m. Neurol Ther. 2023 Aug;12(4):1309-1318. doi: 10.1007/s40120-023-00497-2. Epub 2023 Jun 8. Neurol Ther. 2023. PMID: 37289421 Free PMC article.
25 results